Altesa BioSciences Selected for Oral Presentation at the American Thoracic Society 2026 International Congress

B Presentation details the impact of vapendavir on quality of life and lung function ATLANTA, April 30, 2026 /PRNewswire/ — Altesa BioSciences, a clinical-stage pharmaceutical company…
posteditor
posteditor
Articles: 17424

Other News